Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Y Wo

Showing results (61-70 of 144) with videos related to

Pageof 15
Sort By:
The British Journal of Radiology|June 15, 2017
Standard fractionation external beam radiotherapy with and without intraoperative radiotherapy for locally recurrent rectal cancer: the role of local therapy in patients with a high competing risk of death from distant diseaseAmar U Kishan, Justin C Voog, Jonathan Wiseman, et al.
Practical Radiation Oncology|May 3, 2017
Irradiation of anatomically defined pelvic subsites and acute hematologic toxicity in anal cancer patients undergoing chemoradiationBrent Rose, Devarati Mitra, Theodore S Hong, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2025
Long-Term Results of a Phase 2 Study of Adjuvant Proton Radiation Therapy for Node-Positive Cancer of the Uterus and CervixAndrea L Russo, Nicolas Depauw, Nora K Horick, et al.
American Journal of Clinical Oncology|October 15, 2016
Intraoperative Radiotherapy in the Era of Intensive Neoadjuvant Chemotherapy and Chemoradiotherapy for Pancreatic AdenocarcinomaFlorence K Keane, Jennifer Y Wo, Cristina R Ferrone, et al.
The Lancet. Gastroenterology & Hepatology|February 24, 2025
Emerging evidence-based role for external-beam radiation therapy in hepatocellular carcinomaStephanie O Dudzinski, Neil B Newman, Jeff McIntyre, et al.
Cancer|October 25, 2011
Long-term outcomes of neoadjuvant chemotherapy before chemoradiation for locally advanced pancreatic cancerNils D Arvold, David P Ryan, Andrzej Niemierko, et al.
Annals of Surgical Oncology|November 24, 2019
Intraoperative Radiation Therapy (IORT) for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (BR/LA PDAC) in the Era of Modern Neoadjuvant Treatment: Short-Term and Long-Term OutcomesJon M Harrison, Jennifer Y Wo, Cristina R Ferrone, et al.
Histopathology|February 8, 2020
Pancreatic ductal adenocarcinoma: tumour regression grading following neoadjuvant FOLFIRINOX and radiationAzfar Neyaz, Elisabeth S Tabb, Angela Shih, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 16, 2013
Phase I study of neoadjuvant accelerated short course radiation therapy with photons and capecitabine for resectable pancreatic cancerJennifer Y Wo, Harvey J Mamon, Cristina R Ferrone, et al.
Cancer Journal (Sudbury, Mass.)|January 22, 2025
Severe Lymphopenia Predicts Poorer Survival in Patients With Rectal Cancer Undergoing Neoadjuvant ChemoradiationDaniel W Kim, Grace Lee, Elise M Cai, et al.
Pageof 15

Showing results (61-70 of 144) with videos related to

Sort By:
Pageof 15
The British Journal of Radiology|June 15, 2017
Standard fractionation external beam radiotherapy with and without intraoperative radiotherapy for locally recurrent rectal cancer: the role of local therapy in patients with a high competing risk of death from distant diseaseAmar U Kishan, Justin C Voog, Jonathan Wiseman, et al.
Practical Radiation Oncology|May 3, 2017
Irradiation of anatomically defined pelvic subsites and acute hematologic toxicity in anal cancer patients undergoing chemoradiationBrent Rose, Devarati Mitra, Theodore S Hong, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2025
Long-Term Results of a Phase 2 Study of Adjuvant Proton Radiation Therapy for Node-Positive Cancer of the Uterus and CervixAndrea L Russo, Nicolas Depauw, Nora K Horick, et al.
American Journal of Clinical Oncology|October 15, 2016
Intraoperative Radiotherapy in the Era of Intensive Neoadjuvant Chemotherapy and Chemoradiotherapy for Pancreatic AdenocarcinomaFlorence K Keane, Jennifer Y Wo, Cristina R Ferrone, et al.
The Lancet. Gastroenterology & Hepatology|February 24, 2025
Emerging evidence-based role for external-beam radiation therapy in hepatocellular carcinomaStephanie O Dudzinski, Neil B Newman, Jeff McIntyre, et al.
Cancer|October 25, 2011
Long-term outcomes of neoadjuvant chemotherapy before chemoradiation for locally advanced pancreatic cancerNils D Arvold, David P Ryan, Andrzej Niemierko, et al.
Annals of Surgical Oncology|November 24, 2019
Intraoperative Radiation Therapy (IORT) for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (BR/LA PDAC) in the Era of Modern Neoadjuvant Treatment: Short-Term and Long-Term OutcomesJon M Harrison, Jennifer Y Wo, Cristina R Ferrone, et al.
Histopathology|February 8, 2020
Pancreatic ductal adenocarcinoma: tumour regression grading following neoadjuvant FOLFIRINOX and radiationAzfar Neyaz, Elisabeth S Tabb, Angela Shih, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 16, 2013
Phase I study of neoadjuvant accelerated short course radiation therapy with photons and capecitabine for resectable pancreatic cancerJennifer Y Wo, Harvey J Mamon, Cristina R Ferrone, et al.
Cancer Journal (Sudbury, Mass.)|January 22, 2025
Severe Lymphopenia Predicts Poorer Survival in Patients With Rectal Cancer Undergoing Neoadjuvant ChemoradiationDaniel W Kim, Grace Lee, Elise M Cai, et al.
Pageof 15